Groundbreaking Advancements Propel HIV Vaccine Research Forward

Updated on: June 03,2024

Groundbreaking Advancements Propel HIV Vaccine Research Forward

Updated on:June 03,2024

Spider venom-based heart drug is a step closer

JANUARY 17, 2024byUniversity of QueenslandPipette harvesting drop of venom from funnel web spider. Credit: University of QueenslandA spider venom molecule being investigated by a University of Q

Updated on: March 30,2024

Spider venom-based heart drug is a step closer

JANUARY 17, 2024byUniversity of QueenslandPipette harvesting drop of venom from funnel web spider. Credit: University of QueenslandA spider venom molecule being investigated by a University of Q

Updated on:March 30,2024

Reprogramming tissue mechanically to promote wound healing

by Jan Berndorff,Paul Scherrer InstituteImplanted PR cells show rejuvenation properties in an aged skin model. Credit:Aging Cell(2023). DOI: 10.1111/acel.14032Researchers at PSI and

Updated on: December 25,2023

Reprogramming tissue mechanically to promote wound healing

by Jan Berndorff,Paul Scherrer InstituteImplanted PR cells show rejuvenation properties in an aged skin model. Credit:Aging Cell(2023). DOI: 10.1111/acel.14032Researchers at PSI and

Updated on:December 25,2023

Scientists reveal new TEV-mediated αPD-L1-specific therapy resistance mechanism

by Zhejiang UniversityTEV PD-L1 competes with PD-L1 on tumor cells to bind αPD-L1.a,bMC38-EVs and PC3-EVs (1 μg) (a) or MC38 and PC3 cells (1 × 105) (b) were coincubated with the ind

Updated on: December 27,2023

Scientists reveal new TEV-mediated αPD-L1-specific therapy resistance mechanism

by Zhejiang UniversityTEV PD-L1 competes with PD-L1 on tumor cells to bind αPD-L1.a,bMC38-EVs and PC3-EVs (1 μg) (a) or MC38 and PC3 cells (1 × 105) (b) were coincubated with the ind

Updated on:December 27,2023

Burn injury disrupts gut microbiome and weakens intestinal mucus barrier, finds study

FEBRUARY 5, 2024by TranSpreadThe effect of burn injury on colonic tissue and intestinal mucus barrier. (a) hematoxylin and eosin (HE) and Alcian blue/periodic acid Schiff (AB/PAS) staining of the dist

Updated on: March 29,2024

Burn injury disrupts gut microbiome and weakens intestinal mucus barrier, finds study

FEBRUARY 5, 2024by TranSpreadThe effect of burn injury on colonic tissue and intestinal mucus barrier. (a) hematoxylin and eosin (HE) and Alcian blue/periodic acid Schiff (AB/PAS) staining of the dist

Updated on:March 29,2024

Research offers new insights into how breakdown of omega-6 fatty acids influences metabolism

by Eva Maria Wellnitz, Universitätsmedizin MannheimGeneration and validation of aldh9a1b−/- zebrafish line using CRISPR/Cas9 technology (A) Neighbor-joining phylogenetic bootstrap tree of amino acid s

Updated on: December 26,2023

Research offers new insights into how breakdown of omega-6 fatty acids influences metabolism

by Eva Maria Wellnitz, Universitätsmedizin MannheimGeneration and validation of aldh9a1b−/- zebrafish line using CRISPR/Cas9 technology (A) Neighbor-joining phylogenetic bootstrap tree of amino acid s

Updated on:December 26,2023

Urine biomarkers can outperform serum biomarkers in certain diseases

by KeAi Communications Co.Urine biomarkers can outperform serum biomarkers in certain diseases. Credit: Xue C, et al.In recent decades, the emphasis of biomarker research has centered around blood-bas

Updated on: January 04,2024

Urine biomarkers can outperform serum biomarkers in certain diseases

by KeAi Communications Co.Urine biomarkers can outperform serum biomarkers in certain diseases. Credit: Xue C, et al.In recent decades, the emphasis of biomarker research has centered around blood-bas

Updated on:January 04,2024

Putting the brakes on chronic inflammation: Study discovers link between two key pathways

by Weill Cornell Medical CollegeA single-cell atlas of IL-23 responses in the small intestine identifies CTLA-4+ILC3s. Credit:Nature(2024). DOI: 10.1038/s41586-024-07537-3Scient

Updated on: June 15,2024

Putting the brakes on chronic inflammation: Study discovers link between two key pathways

by Weill Cornell Medical CollegeA single-cell atlas of IL-23 responses in the small intestine identifies CTLA-4+ILC3s. Credit:Nature(2024). DOI: 10.1038/s41586-024-07537-3Scient

Updated on:June 15,2024

Pharmacists could bridge a health care gap by offering more sexual health services

by Adrianna MacPherson,University of AlbertaPharmacy professor and interim dean Christine Hughes is co-author of a study that suggests pharmacists are well positioned to play a key role in reduc

Updated on: May 16,2024

Pharmacists could bridge a health care gap by offering more sexual health services

by Adrianna MacPherson,University of AlbertaPharmacy professor and interim dean Christine Hughes is co-author of a study that suggests pharmacists are well positioned to play a key role in reduc

Updated on:May 16,2024

Higher Soft Drink Consumption Linked to Increased Risk of Liver Disease

Updated on: October 04,2024

Higher Soft Drink Consumption Linked to Increased Risk of Liver Disease

Updated on:October 04,2024

ADHD drug shortages: What to expect if you take Vyvanse and can't access your usual dose

by Alison Poulton,The ConversationCredit: Pixabay/CC0 Public DomainImagine you or your child has attention deficit hyperactivity disorder (ADHD), and after several weeks, or even months, you&#39

Updated on: March 22,2024

ADHD drug shortages: What to expect if you take Vyvanse and can't access your usual dose

by Alison Poulton,The ConversationCredit: Pixabay/CC0 Public DomainImagine you or your child has attention deficit hyperactivity disorder (ADHD), and after several weeks, or even months, you&#39

Updated on:March 22,2024

US approves first drug for severe form of fatty liver disease

Credit: Pixabay/CC0 Public DomainThe US Food and Drug Administration (FDA) on Thursday approved the first medication for people with a severe type of non-alcoholic fatty liver disease.Madrigal Pharmac

Updated on: March 20,2024

US approves first drug for severe form of fatty liver disease

Credit: Pixabay/CC0 Public DomainThe US Food and Drug Administration (FDA) on Thursday approved the first medication for people with a severe type of non-alcoholic fatty liver disease.Madrigal Pharmac

Updated on:March 20,2024